According to Cognitive Market Research, the global Benazepril market size will be USD 102514.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 5.50% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 57562.4 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 30754.26 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 23578.27 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 5125.7 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 2050.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
Chronic kidney disease (CKD) is the fastest increasing market segment for Benazepril
